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Two-photon excited photodynamic therapy (PDT) has the potential to provide a highly targeted 
treatment for neoplastic diseases, as excitation can be pin-pointed to small volumes at the laser 
focus. In addition, two-photon PDT offers deeper penetration into mammalian tissue due to the 10 
longer wavelength of irradiation. Here we report the one-photon and two-photon excited PDT 
results for a collection of conjugated porphyrin dimers with high two-photon absorption cross-
sections. These dimers demonstrate high one-photon PDT efficacy against a human ovarian 
adenocarcinoma cell line (SK-OV-3) and exhibit no significant dark-toxicity at concentrations of 
up to 20 µM. Their one-photon excited PDT efficiencies, following irradiation at 657 nm, approach 15 
that of Visudyne
®
, a drug used clinically for PDT. We investigated and optimised the effect of the 
photosensitiser concentration, incubation time and the light dose on the PDT efficacy of these 
dimers. These studies led to the selection of P2C2-NMeI as the most effective porphyrin dimer. We 
have demonstrated that P2C2-NMeI undergoes a two-photon activated process following excitation 
at 920 nm (3.6–6.8 mW, 300 fs, 90 MHz) and compared it to Visudyne
®
. We conclude that the in 20 
vitro two-photon PDT efficacy of P2C2-NMeI is about twice that of Visudyne
®
. This result 
highlights the potential of this series of porphyrin dimers for two-photon PDT.  
 
Introduction 
Photodynamic therapy (PDT) uses a light-activated drug, 25 
known as a photosensitiser, to treat neoplastic diseases.
1-8
 The 
treatment is relatively benign and gives good cosmetic 
outcomes. One of the major drawbacks is that the drugs are 
excited by visible light which cannot penetrate deeply into 
tissues.
9-13
 Furthermore, the majority of commercial 30 
photosensitisers show little discrimination in uptake in 
diseased cells vs. normal healthy tissue.
14
 Both of these 
limitations may be reduced by exciting the photosensitiser via 
simultaneous two-photon absorption (TPA). Not only does 
two-photon excitation require near-IR light which is capable 35 
of travelling further through tissues than visible light, but also 
the nonlinear process restricts absorption to the laser focus.
15, 
16
 Thus greater treatment depths and highly-selective targeting 
may be achieved by two-photon PDT. 
 The efficiency by which a photosensitiser undergoes two-40 
photon absorption is quantified by its TPA cross-section (!), 
measured in Göppert-Mayer units (1 GM = 10
–50
 cm
4
 s 
photon
–1
 molecule
–1
). The TPA cross-sections of existing 
photosensitisers are in the order of 1–100 GM which is too 
small to be clinically useful.
17
 Two-photon PDT has been 45 
demonstrated in ovo by Cramb and co-workers; blood vessels 
in the chorioallantoic membrane were occluded by two-photon 
activation of the commercial photosensitiser Visudyne
®
.
18
 
However, the low TPA cross-section of the drug necessitated 
a high light intensity which was close to the photodamage 50 
threshold.
19
 Thus phototherapeutic compounds with higher 
TPA cross-sections are needed to expand the clinical 
applications of two-photon excited PDT. 
  With the adoption of multi-photon imaging and micro-
fabrication as standard techniques,
20,21
 interest in designing 55 
chromophores with large two-photon cross-sections has 
expanded rapidly.
22-26
 Recently, focus has turned to 
compounds for two-photon excited PDT, although only a few 
of these have shown in vitro activity and few in vivo studies 
have been published.
27-33
 60 
 We have recently reported a family of ionic conjugated 
porphyrin dimers with peak TPA cross-sections as large as 
17,000 GM (Fig. 1).
34
 Since these molecules exhibit strong 
linear absorption at 700–800 nm, they are also promising for 
long wavelength excitation one-photon PDT. This work led to 65 
the first demonstration of in vivo two-photon PDT using a 
photosensitiser specifically designed for efficient multi-
photon excitation.
34
 In this sequence of papers, we describe 
the adaptation of the hydrophobic porphyrin dimer structure
35
 
to create drugs with excellent photophysical properties for 70 
PDT and which accumulate efficiently in human ovarian 
cancer cells (SK-OV-3).
36
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 Here we present a systematic study of the in vitro one- and 
two-photon phototoxic properties of the cationic (P2-NMeI, 
P2C2-NMeI and P2-NMe3OAc) and anionic (P2-SO3NH4 and 75 
P2C2-CO2NH4) porphyrin dimers (Fig. 1). 
Results and Discussion 
The phototoxicity of a compound depends on 1) the extinction 
coefficient at the activation wavelength, 2) the quantum yield 
of singlet oxygen generation ("#), 3) the stability of the 80 
compound in the biological environment, and 4) the 
intracellular localisation of the photosensitiser i.e. the ability 
of the compound to target vulnerable organelles. All four 
factors contribute to the PDT efficiency of a photosensitiser. 
 As reported previously,
36
 fluorescence imaging shows that 85 
the ionic porphyrin dimers, P2-NMeI, P2C2-NMeI, P2-
NMe3OAc, P2-SO3NH4 and P2C2-CO2NH4, accumulate 
inside human ovarian adenocarcinoma epithelial cells (SK-
OV-3). The dimers exhibit punctate fluorescence in the 
cytoplasm, and they have significant singlet oxygen yields in 90 
pure water ("! = 0.1–0.6),
36
 despite aggregation. These singlet 
oxygen production efficiencies are comparable to those of 
clinical photosensitisers.
37
 Moreover, the singlet oxygen 
yields are substantially higher in methanol ("! = 0.5–0.9), so 
the in vivo singlet oxygen yields should also be high, since the 95 
dimers are likely to be disaggregated in the hydrophobic 
compartments of cells, where they are bound to proteins or 
lipids.  
 The porphyrin dimers exhibit intense absorption in the red 
and near-IR region (600–850 nm), Fig. 1. The closely related 100 
dimers, P2-NMeI, P2-NMe3OAc and P2-SO3NH4, have their 
longest wavelength absorption maxima at 705–712 nm, ca 
62,000 M
–1
 cm
–1
. The extinction coefficients of the extended 
"-conjugated dimers P2C2-CO2NH4 and P2C2-NMeI are even 
greater, close to 120,000 M
–1
 cm
–1
 at 746 nm and 769 nm 105 
respectively. In this respect, the dimers offer considerable 
improvement over the majority of commercial and clinically-
used photosensitisers. For example, the longest wavelength 
absorption maximum is 38,000 M
–1
 cm
–1
 at 690 nm for 
verteporfin (Visudyne®), 42,000 M
–1
 cm
–1
 at 732 nm for 110 
lutetium texaphyrin (Lutex
®
)
38
 and 109,000 M
–1
 cm
–1
 at 763 
nm for Tookad
®
.
39
 
 The absorption of the photosensitisers at 657 nm (the 
emission peak of the light emitting diode, LED, light source 
used in this study) is of primary importance for the one-115 
photon PDT experiments reported here. The absorption 
spectra of the three dimers P2-NMeI, P2-NMe3OAc and P2-
SO3NH4 overlap most efficiently with the LED emission, 
their extinction coefficients are approximately 36,000 M
–1
 cm
–
1
 at 657 nm, compared to 25,000 and 22,000 M
–1
 cm
–1
 for 120 
P2C2-NMeI and P2C2-CO2NH4 respectively (Fig. 1). The 
absorption of the control photosensitiser verteporfin at 657 nm 
is weak compared to the dimers; its extinction coefficient is 
only 4500 M
–1
 cm
–1
 at 657 nm. 
 125 
 
 
In vitro one-photon PDT  
There is no single standard method for measuring in vitro 
phototoxicity because of the large number of variables 130 
relating to the drug, light dose and target disease. In this study 
we used the adherent human epithelial ovarian 
adenocarcinoma cell line, SK-OV-3, grown in multiwell 
plates. These cells were selected since they are easy to 
maintain as a uniform monolayer which facilitates two-photon 135 
irradiation. Lasers are the most common light sources for PDT 
as they can deliver focused intense monochromatic light, 
although they may be replaced by cheap, powerful (> 1 W) 
LEDs.
40
 There are many methods for measuring cell survival 
after PDT in vitro. Cell death may be quantified by measuring 140 
enzyme activity,
41
 membrane permeability
42
 or redox 
potentials.
43
 
 We used a purpose-built array of 657 nm LEDs (full width 
at half maximum = 22 nm) for the one-photon PDT 
experiments, as shown in Fig. 2 (emission spectrum in Fig. 1). 145 
This allowed us to rapidly and reproducibly screen the 
compounds. The output of the LEDs (3.2 mW) was measured 
 
Fig. 1 Structures of the conjugated porphyrin dimers and their linear 
absorption spectra, shown together with that of the commercial drug 
verteporfin (Visudyne), measured in DMF with 1% pyridine. Included for 
comparison is the Gaussian (FWHM = 22 nm) emission profile of the red 
LEDs used for the one-photon excited PDT experiments.  
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to be constant over a period of more than 4 hours and they 
were aligned directly under the sample wells (0.34 cm
2
) to 
achieve uniform irradiation of the cells (9.4 mW cm
–2
). The 150 
cell viability was measured 48 hours after irradiation using a 
colourimetric proliferation assay (CellTiter 96
®
 AQueous One 
solution cell proliferation assay). The 48 hour delay was 
sufficient to account for both apoptotic and necrotic 
mechanisms of cell death. Exposure to the red LED light for 155 
one hour in the absence of photosensitiser had no measurable 
effect on cell survival. 
 In preliminary experiments, blue light from 470 nm LEDs 
(FWHM = 34 nm, 1.7 mW, 5.0 mW cm
–2
) was also tested. 
However, exposure to this light for more than 5 minutes 160 
reduced the viability of SK-OV-3 cells, even in the absence of 
a photosensitiser, Fig. S1, ESI. Blue light has been reported to 
be inherently mutagenic and is less effective for clinical PDT, 
as it is absorbed by endogenous chromophores and is strongly 
scattered by live tissue (resulting in lower penetration 165 
depth).
44, 45
 Therefore red light (657 nm) was used throughout 
this study. 
 For a given sensitiser the following parameters can be 
optimised to maximise the PDT effect: 1) the incubation time 
prior to treatment, 2) the photosensitiser concentration, and 3) 170 
the light dose. We tested and optimised all three parameters 
for the family of porphyrin dimers shown in Fig. 1. 
Incubation time-dependent phototoxicity of the dimers 
The porphyrin dimers have limited solubility in water, as 
discussed previously.
35,36
 Hence they were dissolved in 175 
DMSO (dimethyl sulfoxide), as 1.0 mM stock solutions, and 
then diluted in the culture medium (Dulbecco’s Modified 
Eagle’s Medium, DMEM) to the required concentration. The 
dimer uptake in SK-OV-3 cells was monitored by confocal 
fluorescence microscopy, as reported earlier.
36
 In the previous 180 
study, we reported the the mean intracellular fluorescence 
intensity, while here we compare the influence of the 
incubation time on the PDT efficiency. 
 It is important that a photosensitiser is not significantly 
dark-toxic, i.e. it should be harmless in the absence of light. 185 
The porphyrin dimers demonstrated insignificant dark cyto-
toxicity when cells were incubated in 10 µM solutions for up 
to 18 hours (see the following section). Promisingly, all the 
dimers induced a significant PDT effect when irradiated with 
the 657 nm LED light. With an irradiation time of 10 minutes 190 
the three cationic dimers P2-NMeI, P2C2-NMeI and 
P2-NMe3OAc, showed a gradual increase in PDT effect with 
increasing incubation time (Fig. 3). From the graph in Fig. 3 it 
can be seen that, under the conditions used (10 min. 
irradiation), P2C2-NMeI kills 50 % of the cells with an 195 
incubation time of only 30 minutes, whereas P2-NMe3OAc 
and P2-NMeI need around 2.0 and 3.5 hours respectively. On 
the other hand, the PDT effect of the two anionic dimers 
P2-SO3NH4 and P2C2-CO2NH4, reaches a plateau with 2 
hours incubation and the maximal achieved PDT effect is less 200 
than with the cationic dimers (even though a longer irradiation 
time of 40 minutes was used for the anionic dimers compared 
to 10 min for cationic dimers). Of the two anionic dimers, P2-
SO3NH4 achieves a greater PDT effect with shorter incubation 
times; its maximum cell kill is around 50 % after 30 minutes, 205 
whereas P2C2-CO2NH4 requires 18 hours incubation to reduce 
the cell viability by only 43 ± 8 %. These trends correspond 
closely to those reported from the fluorescence microscopy 
experiments.
36
 That study found that the anionic dimer P2-
SO3NH4 showed rapid saturation of intracellular emission 210 
(within 2 hours), while the cationic dimers required 5–10 
hours incubation to achieve their maximal intracellular 
fluorescence, and appeared to accumulate in the cells at a 
higher concentration.
36
 
 Since the cationic dimers appeared to be the more 215 
promising photosensitisers, the two anionic dimers were not 
investigated further at this stage.  
 
 
 
Fig. 2 Experimental setup for one-photon irradiation: (a) LED array with 
flat-bottomed 96-well plates placed on top. (b) cross section, (c) circuit 
diagram for the light box. The LED array runs on a 24 V rechargeable 
battery. The resistors for the red channels (680 #) and blue channels (255 
#) give a current of 20 mA for each row of six LEDs. The light intensities 
in the cell wells were 9.4 and 5.0 mW cm-2 respectively for the red (657 
nm) and blue (470 nm) LEDs. 
 
Fig. 3 Phototoxic effect of the porphyrin dimers on the viability of SK-
OV-3 cells versus incubation time: P2-NMeI (! open diamond ), P2C2-
NMeI (! black triangle) and P2-NMe3OAc (" black circle), P2-SO3NH4 
(! black diamond) and P2C2-CO2NH4 (# open circle). The cells were 
incubated with the respective photosensitiser for various times before 
light exposure with 657 nm, 9.4 mW cm–2. The light dose for the cationic 
dimers was 10 min (5.6 J cm–2) whereas it was 40 min (23 J cm–2) for the 
anionic dimers. Cell viability percentage is calculated relative to control 
cells that had been administered the same light dose without drug. The 
error bars denote one standard deviation from 5 replicates. For additional 
data see Fig. S2-S6, ESI. 
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 220 
Concentration-dependent phototoxicity of the cationic dimers 
The dark-toxicity and phototoxicity of the cationic porphyrin 
dimers were investigated as a function of the photosensitiser 
concentration. At concentrations below 20 µM no significant 
dark-toxicity was observed for any of the drugs after 18 hours 225 
incubation, as shown in Fig. 4a, which is encouraging given 
this long incubation time. At 40 µM concentration, there may 
be slight dark-toxicity, although the cell viability remains 
above 80 % for all of the photosensitisers. In Fig. 4b the cell 
survival is reported using the same 18 hour incubation period 230 
followed by 4 minutes light exposure. From this graph the 
photosensitiser concentration required to kill 50 % of the 
cells, LD50(drug), may be estimated. The LD50(drug) values 
for P2C2-NMeI and P2-NMe3OAc are similar, 2.8 ± 0.7 µM 
and 3.9 ± 0.3 µM respectively, whereas P2-NMeI requires a 235 
substantially higher concentration of 13.7 ± 1.5 µM. A 
concentration of 10 µM was used for the subsequent in vitro 
PDT experiments since this gave around 40 % cell kill with 
P2-NMeI and an even greater reduction in cell viability (80–
90 %) with P2C2-NMeI and P2-NMe3OAc. 240 
Light exposure-dependent phototoxicity of the cationic 
dimers in relation to Visudyne 
The one-photon excited PDT efficiencies of the three cationic 
dimers were compared to Visudyne by measuring the light 
exposure time required to kill 50 % of the cells, using 245 
identical photosensitiser concentrations (10 µM) and 
incubation times (4 hours). From preceding studies it has been 
established that Visudyne is rapidly taken up by cells and only 
requires an incubation time of around 2.5 hours to maximise 
its intracellular concentration.
46
 Thus, an incubation time of 4 250 
hours was chosen as a compromise between the optimal 
incubation times for all the photosensitisers. When using the 
fixed incubation conditions of 10 µM for 4 hours, we found 
that the irradiation time required to kill 50 % of the cells, 
LD50(light), was 0.5 ± 0.1 minutes for Visudyne, 2.5 ± 0.3 255 
minutes for P2-NMe3OAc, 3.1 ± 0.8 minutes for P2C2-NMeI 
and 4.7 ± 0.2 minutes for P2-NMeI (Fig. 5). Hence, the 
irradiation time required to kill half the cells was about 5 to 6 
times greater with P2C2-NMeI and P2-NMe3OAc than with 
Visudyne and around 10 times larger with P2-NMeI. The 260 
somewhat extended irradiation time required for P2-NMeI 
reflects the finding that with 4 hours incubation the phototoxic 
effect of dimer P2-NMeI is less than dimers P2C2-NMeI and 
P2-NMe3OAc, Fig. 3. With incubation times longer than 6 
hours, all the dimers would be expected to show similar 265 
LD50(light) values. 
 
Optimised one-photon PDT efficiency of the porphyrin 
dimers 
Finally, a one-photon PDT experiment was performed under 270 
optimised conditions, using 10 µM solution, incubated with 
 
Fig. 4 (a) Dark-toxicity and (b) phototoxicity of porphyrin dimers 
P2-NMeI (! open diamond ), P2C2-NMeI (! black triangle) and P2-
NMe3OAc (" black circle) towards SK-OV-3 cells as a function of 
photosensitiser concentration. The cells were incubated with the 
respective photosensitiser for 18 h and if required, the cells were exposed 
to a 657 nm, 9.4 mW cm–2, 4 min light dose (2.3 J cm–2). The cell 
viability is calculated relative to control cells that had been administered 
the same light dose without a drug. The error bars denote one standard 
deviation from 5 replicates. For additional data see Fig. S7-S9, ESI. 
 
Fig. 5 One-photon effect on SK-OV-3 cell viability versus light exposure 
with porphyrin dimers P2-NMeI (! open diamond ), P2C2-NMeI (! 
black triangle) and P2-NMe3OAc (" black circle) compared to Visudyne 
($ black square). The cells were incubated with the respective 10 µM 
photosensitiser for 4 h before light exposure with 657 nm, 9.4 mW cm–2. 
Cell viability percentage is calculated relative to control cells that had 
been administered the same light dose without drug. The error bars denote 
one standard deviation from 5 replicates. For additional data see Fig. S10-
S13, ESI. 
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the SK-OV-3 cells for 6 hours prior to light exposure. 
Excellent PDT effects were achieved with all three cationic 
dimers with an irradiation time of 20 minutes at 657 nm. As 
can be seen from Fig. 6, cell survival rates are less than 5 % 275 
for dimers P2-NMeI and P2C2-NMeI and less than 10 % for 
the dimer P2-NMe3OAc. Using the same incubation and 
irradiation conditions, significantly smaller PDT effects were 
achieved with the anionic dimers, P2-SO3NH4 (62 ± 5 %) and 
P2C2-CO2NH4 (89 ± 10 %). While the commercial drug 280 
Visudyne shows close to 100 % cell death under the same 
conditions.  
 As discussed earlier there are many factors which influence 
the PDT efficiency of a drug. The 657 nm extinction 
coefficients of the cationic dimers and Visudyne are 285 
summarised in Table 1, together with the corresponding 
LD50(drug) and LD50(light) values. If we account for the 
varying extinction coefficients of the photosensitisers at the 
excitation wavelength and include the results from the anionic 
dimers, the phototherapeutic efficiencies increase in the order 290 
P2C2-CO2NH4 < P2-SO3NH4 < P2-NMeI < P2-NMe3OAc < 
P2C2-NMeI < Visudyne. The considerable research that has 
been undertaken in designing and formulating the commercial 
drug is evident from its excellent one-photon PDT efficiency. 
Compared to the other dimers in this study P2C2-NMeI 295 
showed the lowest dark-toxicity and greatest PDT efficiency, 
and its smaller extinction coefficient at 657 nm results in a 
better LD50(light) and similar LD50(drug) to that of 
P2-NMe3OAc. From incubation studies in SK-OV-3 cells 
P2C2-NMeI produces a 90 ± 5 % cell kill with 4 hours 300 
incubation (2260 mJ cm
–2
), which is comparable to the effect 
of Visudyne. The high singlet oxygen yield of P2C2-NMeI 
("! = 0.6 in methanol) in combination with the highest 
measured (for our porphyrin dimers) two-photon cross-section 
(! = 17,000 GM at 916 nm)36 make this drug the most 305 
promising two-photon excited PDT sensitiser from this 
family. Therefore, P2C2-NMeI was selected for in vitro two-
photon PDT studies. 
 
Two-photon excited PDT efficiency of porphyrin dimer P2C2-310 
NMeI 
One of the key benefits of two-photon excitation is the highly 
targeted treatment that can be achieved. However, since the 
excitation volume is so small (ca 1–1000 µm
3
) it would be 
difficult to quantify the in vitro phototoxic effect by the same 315 
colourimetric method used for the one-photon cell kill 
experiments. The two-photon induced therapeutic effect was 
instead evaluated using a procedure developed by Wilson and 
co-workers.
19
 This technique employs a confocal laser 
scanning microscope to irradiate and measure a two-photon 320 
PDT effect using a fluorescent dye-based cell-permeability 
assay.
46
 
 Firstly, we sought to confirm that the PDT effect of 
P2C2-NMeI in this experiment is really due to a two-photon 
absorption process, and not, for example, due to activation of 325 
the long-wavelength tail of the photosensitiser one-photon 
absorption. This can be demonstrated by the characteristic 
quadratic dependence of the light dose, LD50(light), on the 
irradiation intensity. Hence, a monolayer of SK-OV-3 cells 
was incubated for 18 hours with P2C2-NMeI and discrete 330 
areas (230 $ 230 µm) were irradiated with varying doses of 
920 nm light (300 fs, 90 MHz) using a 40$, 1.2 NA objective. 
The cell-viability was determined 5 hours after irradiation 
using the cell-permeable DNA stain, Hoechst 33258 and the 
dead-cell indicator Sytox orange. Examples of confocal 335 
images of individual cell areas after two-photon excited PDT 
are displayed in Fig. 7, showing increasing degrees of cell 
death at longer exposure times. 
 As in the case of one-photon PDT, the LD50(light) for 
P2C2-NMeI was calculated by plotting the cell viability as a 340 
function of exposure time (number of scans) as seen in Fig. 
8a. The log[LD50(light)] is plotted against log[laser power
–1
] 
and the gradient of a linear fit to these points is 2.0 ± 0.2, 
confirming two-photon activation of P2C2-NMeI at 920 nm, 
Fig. 8b. 345 
 
Table 1 Extinction coefficients and one-photon excited PDT efficiencies 
for cationic porphyrin dimers and the commercial drug Visudyne. 
Photosensitiser (PS) 
$ 
(M–1 cm–1)a 
LD50(drug): 
PS conc. (µM)b 
LD50(light): Light 
exposure (min)c 
P2-NMeI 36,000 13.7 ± 1.5 4.7 ± 0.2 
P2C2-NMeI 25,000 3.9 ± 0.3 2.5 ± 0.3 
P2-NMe3OAc 36,000 2.8 ± 0.7 3.1 ± 0.8 
Visudyne 4500 1.0 ± 0.1 0.5 ± 0.1 
a Measured in DMF at 657 nm. 
b 18 h incubation with the photosensitiser, 4 min irradiation at 657 nm. 
c 4 h incubation with 10 µM of the photosensitiser, irradiation at 657 nm. 
 
 
Fig. 6 One-photon effect on SK-OV-3 cell viability using the porphyrin 
dimer photosensitisers. The cells were incubated with 10 µM of the 
respective photosensitiser for 6 h before light exposure. Dark controls in 
grey; light control: cells were exposed to a 657 nm, 9.4 mW cm–2, 20 min 
light dose (11 J cm–2). The error bars denote one standard deviation from 
5 replicates. For additional data see Fig. S14, ESI.  
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 The one- and two-photon PDT efficiencies of porphyrin 
dimer P2C2-NMeI and Visudyne are compared in Fig. 9. As 
presented above, when using continuous wave irradiation (657 
nm, 9.4 mW cm
–2
), 18 hours incubation and 10 µM 350 
concentration, the commercial drug is substantially more 
phototoxic than P2C2-NMeI, even though the extinction 
coefficient of Visudyne is considerably lower at the 
irradiation wavelength, 4500 M
–1
 cm
–1
 compared to 25,000 M
–1
 
cm
–1
 for the dimer, Fig. 9a. The light exposure required to kill 355 
50 % of the cells was 44 s for Visudyne compared to 180 s for 
the dimer. Using the same photosensitiser, concentration and 
incubation conditions the cells were excited by two-photon 
absorption using 920 nm light (300 fs, 90 MHz, 3.9 mW). The 
respective LD50(light) values were reversed under these 360 
excitation conditions, with P2C2-NMeI requiring a shorter 
irradiation time of 110 ± 30 s, compared to 180 ± 30 s for 
Visudyne, see Fig. 9b. The larger TPA cross-section of 
P2C2-NMeI (16,000 GM compared to 46 GM for Visudyne at 
920 nm) compensates in part for its lower photodynamic 365 
efficiency, such that the dimer is a better two-photon 
photosensitiser than Visudyne. From the ratios of the one-
photon extinction coefficients, one-photon PDT efficacies and 
two-photon cross sections, one would expect P2C2-NMeI to 
be about 15 times more effective than Visudyne for two-370 
photon PDT.
46
 However the two-photon efficacy ratio 
measured here is only 1.6. This must reflect the different 
assay conditions used in the two-photon and one-photon PDT 
experiments. P2C2-NMeI appears to be relatively less 
phototoxic towards the closely packed monolayers of cells 375 
used in two-photon PDT, compared to the sparsely dispersed 
cells in the one-photon assay. Another difference between the 
assay conditions is the longer time (48 hours vs. 5 hours) 
between light-exposure and determination of cell-viability in 
the one-photon assay, which makes this procedure more 380 
sensitive to apoptic cell death. 
Conclusions 
The phototoxic properties of a new series of conjugated 
porphyrin dimers with high two-photon absorption cross-
 
Fig. 7 Example confocal images of two-photon excited PDT using porphyrin dimer sensitiser P2C2-NMeI on SK-OV-3 cells; only the central square 
region, indicated by the white box (230$230 µm), was irradiated. The combined transmission and fluorescence images are shown, all nuclei are stained 
with Hoechst 33258 (blue) and cells with compromised plasma membranes are co-stained with Sytox orange (magenta). The central region was irradiated 
with 920 nm (300 fs, 90 MHz, 6.8 mW): (a) 60 scans, (b) 100 scans and (c) 320 scans. 
 
Fig. 8 (a) Dependence of the in vitro two-photon excited PDT effect of 
P2C2-NMeI on the irradiating laser power. Example series of in vitro cell 
viability curves produced using irradiation at 920 nm, 300 fs, 90 MHz and 
5 discrete laser powers: " 6.8, # 5.8, ! 4.9, $ 4.2, and ! 3.6 mW. (b) 
The PDT light dose (number of scans) required to kill 50 % of the cells 
(LD50light) is determined from the cell viability curves in (a) and the 
log[LD50] is plotted against the log[laser power
–1]. The error bars in (a) 
represent the estimated 10 % error in determining cell viability by 
fluorescent staining and in (b) denote one standard error. 
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sections (8000–17,000 GM)
36
 have been explored and 385 
quantified. All five dimers show uptake by SK-OV-3 cells and 
possess high singlet oxygen yields ("! = 0.5–0.9 in 
methanol).
36
 Although the anionic dimers, P2-SO3NH4 and 
P2C2-CO2NH4, demonstrate a significant PDT effect, their 
cationic counterparts, P2C2-NMeI, P2-NMe3OAc and 390 
P2-NMeI, exhibit far greater one-photon PDT efficiencies. 
None of the dimers were measurably toxic in the absence of 
light up to 20 µM concentrations. The cationic dimers treated 
with a short (4 min.) light dose at 657 nm (9.4 mW cm
–2
, 2.3 J 
cm
–2
) show one-photon excited PDT efficiencies that are 395 
comparable to the commercial drug Visudyne; the irradiation 
time required to kill 50 % of the cells was approximately 5 
times longer for P2C2-NMeI and P2-NMe3OAc relative to 
Visudyne and around 10 times longer for P2-NMeI. 
 P2C2-NMeI was selected as the best photosensitiser for 400 
two-photon PDT testing. The two-photon induced PDT effect 
of the porphyrin dimer was shown to be proportional to the 
square of the irradiating power using excitation at 920 nm 
(300 fs, 90 MHz, 3.6–6.8 mW) confirming two-photon 
activation. Under two-photon irradiation P2C2-NMeI was 405 
found to be superior to the commercial drug Visudyne: to kill 
50 % of the cells by two-photon activation, P2C2-NMeI 
required half the light dose needed for Visudyne. In keeping 
with these results, P2C2-NMeI was recently found to be more 
effective than Visudyne during in vivo two-photon PDT blood 410 
vessel closure experiments.
34
 
 The red-shifted absorption spectra and appreciable singlet 
oxygen quantum yields of the porphyrin dimers make them 
ideal candidates for long wavelength one-photon excited PDT, 
thereby aiding deeper treatment depths. However, it is their 415 
extremely large TPA cross-sections that offer the greatest 
benefits. The cationic dimers are promising photosensitisers 
for two-photon induced photodynamic therapy, a new 
treatment modality which would allow the precise targeting of 
diseased tissues. The higher two-photon cross sections of 420 
these new drugs should make them about 350-times more 
effective than Visudyne for two-photon PDT, but further 
optimisation will be required to fully realise this advantage. 
Optimisation of the formulation and use of delivery vehicles, 
such as liposomes, may improve the pharmacokinetics and 425 
microdistribution behaviour of these two-photon drugs, as has 
already been achieved with Visudyne. 
Experimental 
Materials and methods 
Cell culture 430 
SK-OV-3 (human ovarian adenocarcinoma, ECACC) cells 
were grown in phenol red free Dulbecco’s Modified Eagle’s 
Medium (DMEM, Gibco) supplemented with 2 mM 
L-glutamine, penicillin (100 U mL
–1
), streptomycin (100 µg 
mL
–1
) and 10 % fetal bovine serum (FBS, Sigma). The cells 435 
were maintained at 37 °C in a humidified 5 % CO2 
atmosphere. 
 
Photosensitisers and delivery conditions 
The synthesis of the porphyrin dimers P2-NMe3OAc, 440 
P2-NMeI, P2C2-NMeI, P2-SO3NH4 and P2C2-CO2NH4 was 
described previously.
35
 The porphyrin dimers were dissolved 
in DMSO to form 1.0 mM stock solutions, the compounds 
were diluted to their required concentrations in DMEM 
immediately before they were administered to the cells. For 445 
the concentration experiments, 100-fold stock solutions were 
produced in DMSO, such that the DMSO content of the 
incubation solutions was always 1 %. Visudyne (0.95 mg) was 
dissolved in DMEM culture media (2.4 mL) to give 10 µM of 
the active photosensitiser and this solution was vortexed for 3 450 
minutes before it was added to the cells.  
 
One-photon excited PDT 
Testing of the PDT efficiency of the porphyrin dimers was 
performed in microwell plates using the CellTiter 96
®
 455 
AQueous one solution cell proliferation assay (Promega) to 
determine cell viability. SK-OV-3 cells were seeded in flat-
bottomed 96-well plates (Nunc, with a 0.34 cm
2
 growth area) 
at a density of 1250 cells per well in 100 µL of culture media. 
The cells were irradiated 26 h after seeding. At the required 460 
time before the light dose, the media on the cells was replaced 
with the photosensitiser solution. The plates were shielded 
from light during and after incubation. Following incubation 
the wells that required light exposure were irradiated with 
 
Fig. 9 In vitro (a) one-photon (657 nm, 9.4 mW cm-2 continuous wave) 
and (b) two-photon (920 nm, 300 fs, 90 MHz, 4.2 mW) PDT effect of 
porphyrin dimer P2C2-NMeI (! black triangle) compared to Visudyne 
($ black square) using SK-OV-3 cells. The error bars in (a) denote one 
standard deviation from 5 replicates and in (b) represent the estimated 
10 % error in determining cell viability by fluorescent staining.  
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657 nm (9.4 mW cm
–2
, Dotlight GbR, Germany). Following 465 
light exposure the cells were washed three times with 100 µL 
of fresh media and incubated in 100 µL of media for 42 h. The 
cell viability was then determined according to the 
manufacturers instructions. The assay absorbance 
measurements were carried out using a plate reader 470 
(POLARstar OPTIMA, BMG Labtech) at 490 nm and the 
absorbance was directly proportional to the number of living 
cells over the range of cell concentrations used. It was 
necessary to record a background absorbance reading of the 
media, by adding the assay to five wells that did not contain 475 
cells. The average of the background readings was subtracted 
from the average absorbance of each replicate group before 
further data manipulation. Each quoted cell viability value is 
the average from a minimum of 5 replicates, and the reported 
error bars represent ± 1 standard deviation from the mean. 480 
Each experiment was repeated a minimum of three times to 
confirm reproducibility, these replicates are given in the ESI, 
Figures S2-S14. 
 
Two-photon excited PDT 485 
SK-OV-3 cells were seeded in 2-well coverglass chambers 
(Nunc) at a density of 1.3!10
5
 cells per well in 2 mL of 
media. The cells were left to grow to confluence over 3 days, 
such that a uniform monolayer was produced. The cells were 
incubated for 18 h prior to irradiation with 10 "M of the 490 
active photosensitiser. The monolayer was irradiated using a 
confocal laser scanning microscope (LSM 510 Meta NLO, 
Carl Zeiss) coupled to an argon-ion laser (514 nm) and a 
Ti:sapphire laser (Cameleon, Coherent) tunable from 720 to 
960 nm, with 300 fs pulse duration at the sample and 90 MHz 495 
repetition rate. A 40!, numerical aperture (NA) 1.2, air 
objective was used and the focused laser light scanned the 
sample in a raster pattern 512!512 pixels, 230!230 "m, with 
a dwell time of 1.6 "s per pixel. The cell viability was 
determined 5 h after irradiation by staining for 1 h with 10 "g 500 
mL
–1
 Hoechst 33258 and 2.5 "M of Sytox Orange 
(Invitrogen), as described previously.
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